fbpx
Medical Innovation Exchange

Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spin out preps FDA filing

https://www.fiercebiotech.com/biotech/innoviva-acquires-struggling-antibiotic-biotech-entasis-and-lead-drug-sul-dar

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.